Electrical circuit componentry is switchable into a defibrillator circuit to deliver a constant pacing current to a patient. The circuitry may include a constant current source inserted in a leg of the defibrillator circuit or a resistor of selected value inserted between a high voltage source and the...http://www.google.com/patents/US20030088282?utm_source=gb-gplus-sharePatent US20030088282 - Defibrillation pacing circuitry

Electrical circuit componentry is switchable into a defibrillator circuit to deliver a constant pacing current to a patient. The circuitry may include a constant current source inserted in a leg of the defibrillator circuit or a resistor of selected value inserted between a high voltage source and the high side of a defibrillator circuit.

Images(3)

Claims(40)

What is claimed is:

1. The apparatus comprising

an H-bridge defibrillator circuit; and

means switchable into and out of said circuit for causing a constant current to flow through a patient connected to said circuit.

2. The apparatus of claim 1 wherein said means for causing comprises means for imposing a constant voltage across a resistance located in the low side of said circuit.

3. The apparatus of claim 2 wherein said means for imposing comprises a constant voltage source.

4. The apparatus of claim 2 wherein said voltage source applies a constant voltage to a control terminal of a switching device.

5. The apparatus of claim 4 wherein said resistance is located in a leg of said switching device.

22. The apparatus of claim 21 wherein said constant voltage source further comprises a feedback circuit.

23. The apparatus of claim 14 wherein said means for causing comprises a resistance connected between a high voltage source and a high side of said defibrillator circuit.

24. The apparatus of claim 23 wherein the value of said resistance is selected to be much larger than the resistance of said patient.

25. The apparatus of claim 23 further including a switch operable to switch said resistance in and out of said circuit.

26. The apparatus of claim 25 further including a high side driver circuit for activating said switch.

27. A method comprising the steps of:

employing a defibrillator circuit to deliver a defibrillating energy pulse to a patient; and reconfiguring said circuit in response to at least one switching signal to deliver a constant current to said patient.

28. The method of claim 27 wherein said step of reconfiguring comprises switching a resistance into a selected portion of said defibrillator circuit.

29. The method of claim 28 wherein said resistance is switched into a leg of a low side switching device.

30. The method of claim 29 wherein said resistance is switched into series between a high voltage source and a high side of said defibrillator circuit.

31. The method of claim 28 further including the step of applying a constant voltage across said resistance.

32. The method of claim 31 wherein a digital to analog converter is employed in said step of applying a constant voltage.

33. The method of claim 31 wherein a feedback circuit is employed in said step of applying a constant voltage.

34. Electronic circuitry comprising:

a switching device connected in a circuit to assist in sending a current pulse through a patient;

a resistance connected to be switchable in and out of a leg of said switching device; and

a source of constant voltage adapted to be applied across said resistance.

35. The circuit of claim 34 wherein said source of constant voltage comprises a digital to analog converter.

36. The circuit of claim 34 wherein said source of constant voltage comprises a feedback circuit.

37. The circuit of claim 35 wherein said source of constant voltage further comprises a feedback circuit.

38. Electronic circuitry comprising:

a high voltage source;

a switching device connected to assist in sending a current pulse through a patient; and

a resistance switchable into and out of connection between said high voltage source and said switching device and having a value selected to cause a constant current to flow therethrough when said resistance is switched into said connection.

39. The circuitry of claim 38 wherein said high voltage source comprises a capacitor.

40. The circuitry of claim 39 further including a high side driver for controlling the switching of said resistance into and out of said connection.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS

[0001] The invention of the present application may find application in systems such as are disclosed in U.S. patent application entitled “SUBCUTANEOUS ONLY IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR AND OPTIONAL PACER,” having Ser. No. 09/663,607, filed Sep. 18, 2000, pending, and U.S. patent application entitled “UNITARY SUBCUTANEOUS ONLY IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR AND OPTIONAL PACER,” having Ser. No. 09/663,606, filed Sep. 18, 2000, pending, of which both applications are assigned to the assignee of the present application, and the disclosures of both applications are hereby incorporated by reference.

[0003] The present invention relates to apparatus and methods useful in connection with performing electrical cardioversion/defibrillation and optional pacing of the heart.

BACKGROUND OF THE INVENTION

[0004] Defibrillation/cardioversion is a technique employed to counter arrhythmic heart conditions including some tachycardias in the atria and/or ventricles. Typically, electrodes are employed to stimulate the heart with electrical impulses or shocks, of a magnitude substantially greater than pulses used in cardiac pacing.

[0005] Defibrillation/cardioversion systems include body implantable electrodes that are connected to a hermetically sealed container housing the electronics, battery supply and capacitors. The entire system is referred to as implantable cardioverter/defibrillators (ICDs). The electrodes used in ICDs can be in the form of patches applied directly to epicardial tissue, or, more commonly, are on the distal regions of small cylindrical insulated catheters that typically enter the subclavian venous system, pass through the superior vena cava and, into one or more endocardial areas of the heart. Such electrode systems are called intravascular or transvenous electrodes. U.S. Pat. Nos. 4,603,705, 4,693,253, 4,944,300, 5,105,810, the disclosures of which are all incorporated herein by reference, disclose intravascular or transvenous electrodes, employed either alone, in combination with other intravascular or transvenous electrodes, or in combination with an epicardial patch or subcutaneous electrodes. Compliant epicardial defibrillator electrodes are disclosed in U.S. Pat. Nos. 4,567,900 and 5,618,287, the disclosures of which are incorporated herein by reference. A sensing epicardial electrode configuration is disclosed in U.S. Pat. No. 5,476,503, the disclosure of which is incorporated herein by reference.

[0006] In addition to epicardial and transvenous electrodes, subcutaneous electrode systems have also been developed. For example, U.S. Pat. Nos. 5,342,407 and 5,603,732, the disclosures of which are incorporated herein by reference, teach the use of a pulse monitor/generator surgically implanted into the abdomen and subcutaneous electrodes implanted in the thorax. This system is far more complicated to use than current ICD systems using transvenous lead systems together with an active can electrode and therefore it has no practical use. It has in fact never been used because of the surgical difficulty of applying such a device (3 incisions), the impractical abdominal location of the generator and the electrically poor sensing and defibrillation aspects of such a system.

[0007] Recent efforts to improve the efficiency of ICDs have led manufacturers to produce ICDs which are small enough to be implanted in the pectoral region. In addition, advances in circuit design have enabled the housing of the ICD to form a subcutaneous electrode. Some examples of ICDs in which the housing of the ICD serves as an optional additional electrode are described in U.S. Pat. Nos. 5,133,353, 5,261,400, 5,620,477, and 5,658,321 the disclosures of which are incorporated herein by reference.

[0008] ICDs are now an established therapy for the management of life threatening cardiac rhythm disorders, primarily ventricular fibrillation (V-Fib). ICDs are very effective at treating V-Fib, but are therapies that still require significant surgery.

[0009] As ICD therapy becomes more prophylactic in nature and used in progressively less ill individuals, especially children at risk of cardiac arrest, the requirement of ICD therapy to use intravenous catheters and transvenous leads is an impediment to very long term management as most individuals will begin to develop complications related to lead system malfunction sometime in the 5-10 year time frame, often earlier. In addition, chronic transvenous lead systems, their reimplantation and removals, can damage major cardiovascular venous systems and the tricuspid valve, as well as result in life threatening perforations of the great vessels and heart. Consequently, use of transvenous lead systems, despite their many advantages, are not without their chronic patient management limitations in those with life expectancies of >5 years. The problem of lead complications is even greater in children where body growth can substantially alter transvenous lead function and lead to additional cardiovascular problems and revisions. Moreover, transvenous ICD systems also increase cost and require specialized interventional rooms and equipment as well as special skill for insertion. These systems are typically implanted by cardiac electrophysiologists who have had a great deal of extra training.

[0010] In addition to the background related to ICD therapy, the present invention requires a brief understanding of a related therapy, the automatic external defibrillator (AED). AEDs employ the use of cutaneous patch electrodes, rather than implantable lead systems, to effect defibrillation under the direction of a bystander user who treats the patient suffering from V-Fib with a portable device containing the necessary electronics and power supply that allows defibrillation. AEDs can be nearly as effective as an ICD for defibrillation if applied to the victim of ventricular fibrillation promptly, i.e., within 2 to 3 minutes of the onset of the ventricular fibrillation.

[0011] AED therapy has great appeal as a tool for diminishing the risk of death in public venues such as in air flight. However, an AED must be used by another individual, not the person suffering from the potential fatal rhythm. It is more of a public health tool than a patient-specific tool like an ICD. Because >75% of cardiac arrests occur in the home, and over half occur in the bedroom, patients at risk of cardiac arrest are often alone or asleep and can not be helped in time with an AED. Moreover, its success depends to a reasonable degree on an acceptable level of skill and calm by the bystander user.

[0012] What is needed therefore, especially for children and for prophylactic long term use for those at risk of cardiac arrest, is a combination of the two forms of therapy which would provide prompt and near-certain defibrillation, like an ICD, but without the long-term adverse sequelae of a transvenous lead system while simultaneously using most of the simpler and lower cost technology of an AED. What is also needed is a cardioverter/defibrillator that is of simple design and can be comfortably implanted in a patient for many years.

[0013] Moreover, it has appeared advantageous to the inventor to provide the capability in such improved circuitry to provide a signal suitable for pacing when the circuitry is not operating in a defibrillation mode.

SUMMARY OF THE INVENTION

[0014] Accordingly, the invention relates in various aspects to methods and apparatus for selectively converting a defibrillator circuit or circuit for delivering a defibrillating pulse to a patient into circuitry suitable for providing a constant current, useful, e.g., in pacing applications.

BRIEF DESCRIPTION OF THE DRAWINGS

[0015] For a better understanding of the invention, reference is now made to the drawings where like numerals represent similar objects throughout the figures and wherein:

[0016]FIG. 1 is a schematic view of a conventional defibrillator circuit;

[0017]FIG. 2 is a circuit schematic of an illustrative embodiment of the present invention;

[0018]FIG. 3 is a circuit schematic of an alternate embodiment;

[0019]FIG. 4 is a circuit schematic of a second alternate embodiment;

[0020]FIG. 5 is a circuit schematic illustrating one approach to controlling switching in the embodiment of FIG. 4.

DETAILED DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS

[0021]FIG. 1 illustrates a conventional “H-bridge” defibrillator circuit 11. The circuit 11 includes a capacitor C1 which is charged to a high voltage and four switches H1, H2; L1, L2. The capacitor C1 and switches H1, H2; L1, L2 are used to create either a monophasic voltage pulse or a biphasic voltage pulse (FIG. 2) across a patient represented by resistance RPAT. In various applications, the switches H1, H2; L1, L2, may be MOSFETs, IGBTs, or SCRs (silicon controlled rectifiers).

[0022] To create a biphasic waveform such as that shown in FIG. 2, a first pair of switches, e.g., H1 and L2, may be closed to create a first positive pulse 13. Then all of the switches, H1, H2; L1, L2, are turned off during a “center pulse” delay period d1. At the end of the delay period d1, the switches H2 and L1 are both closed, thereby reversing the current through the patient RPAT to produce the negative voltage pulse 17. Typically, digital logic is employed to control the sequencing of the switches H1, H2; L1, L2. In such case, the order of the pulses can be inverted, i.e., the negative going pulse 17 can be produced before the positive going pulse 13. In illustrative applications, the direction of the pulses 13, 17 is, e.g., 1 to 20 millisecond and the inter-pulse delay d1 is, e.g., one millisecond.

[0023]FIG. 3 illustrates circuitry which may operate as a defibrillator circuit during a first selected interval and as a constant current source during a second selected interval. The constant current may be useful, for example, in providing a “pacing” current to a patient RPAT.

[0024] As in FIG. 1, the high side switches H1, H2 employed in FIG. 3 may be IGBTS, MOSFETS, SCRS, or other suitable switches. Such high side switches H1, H2 may be controlled in any suitable manner such as, for example, with pulse transformers, opto-couplers, photo-voltaic generators, or in accordance with the teachings of the application filed on even date herewith on behalf of the same inventor and entitled Simplified Defibrillator Output Circuit, herein incorporated by reference. Digital logic suitable for controlling such circuitry to achieve switching may comprise a programmed microprocessor, microcontroller, discrete logic, or other forms of digital logic control.

[0025] In the circuit of FIG. 3, a resistor R1 is inserted in series with the emitter or the source leg of a first low side transistor Q2, which is preferably an IGBT or MOSFET. Similarly, a resistor R2 is inserted in series with the emitter or source leg of the second low side transistor Q1. A constant voltage is applied across the resistor R1 via a voltage source S1, which applies a voltage VDRIVE to the gate (or base) of the first low side transistor Q2. During operation of the circuit of FIG. 2 as a defibrillator, the transistors Q1, Q2 serve the purposes of low side switches, e.g., L1, L2 of FIG. 1, and the resistors R1, R2 are switched out of the circuit by suitable means, e.g., switches SW1 and SW2. During pacing operation of the circuit of FIG. 3, a suitable switching signal S1 is applied to switch resistor R1 into the circuit.

[0026] In an illustrative application of the circuitry of FIG. 3, the low side transistors Q1, Q2 may be high voltage IGBT or MOSFETs, ranging from 500 volts to 3,000 volts capacity or greater. In the circuit of FIG. 2, the voltage across the resistor R1 is defined by the equation:

VR1=VDRIVE=VT (1)

[0027] where VT is the fixed (constant) threshold voltage of the low side transistor Q1. Thus, if VDRIVE is 15 volts, and VT is in the range of 2-6 volts, VR1 is in the range of 13 to 9 volts. Accordingly, a constant voltage is applied across the resistor R1, resulting in a constant current IRI through the resistor R1, and hence through the patient Rpat.

[0028] As those skilled in the art may appreciate, the threshold voltage VT of the transistor Q1 may vary from device to device. Hence, it is typically necessary to calibrate the circuit in production. In calibrating a circuit like that of FIG. 2, a known voltage is applied and the current through R1 is measured, typically resulting in a large offset, which is compensated for by the system software.

[0029] In order to avoid calibration, the voltage source S1 may be constructed using a feedback circuit employing an operational amplifier A1 as shown in FIG. 4. The op-amp A1 is connected to directly drive the low side transistor Q2, which may comprise, e.g., a MOSFET or IGBT. Use of the operational amplifier A1 removes the uncertainty of the threshold voltage VT SO that the current that passes through the resistor R1 is equal to simply VDRIVE divided by R1. Thus, one can either drive the transistor Q2 with a voltage source and calibrate the system for the VT of the transistor Q2 or use an op-amp circuit to remove the error created by the threshold voltage VT of the transistor Q2.

[0030] During constant current source operation of the circuit of FIG. 3, the appropriate high side switch is on to permit current flow. In addition, the capacitor voltage VC needs to be appropriately selected according to a number of considerations. First, the current that is programmed to go through the patient will generate a voltage VPAT across the patient. Then, in order to make the current source work, the voltage compliance VCOMP of the current source must be appropriately set. In the case of FIG. 3, the voltage compliance VCOMP is the voltage VR1 across the resistor R1 plus the minimum operating voltage VT of the low side transistor Q2. Accordingly, the minimum voltage VHV across the capacitor C1 to current source is defined by the relation:

VHV(min.)=VPAT+VCOMP (2)

[0031] The higher VHV is above VHV (min.), the closer the current source will approach an ideal current source. Another consideration in setting VHV is power consumption.

[0032] The amount of current IR1 can be varied by varying the voltage VDRIVE or by switching in different resistors, e.g., in series with or for R1. From an implementation point of view, it is less attractive to switch in a resistor because such switching requires adding transistors or other switching devices. It is more efficient to simply vary the voltage VDRIVE. Suitable logic circuitry may be provided to select the value of VDRIVE. A DAC (digital to analog converter) is one example of such logic circuitry. As those skilled in the art will appreciate, a DAC is a circuit that generates different voltages in response to corresponding digital codes provided to it. Such a DAC could be used to drive either an input of the op-amp A1 (as illustrated in FIG. 4) or the input (gate) of the transistor Q1. As noted above, an advantage of the op-amp A1 is that it removes the VT term from the VHV equation. Particular parameter ranges for circuitry as configured in FIGS. 2 and 3 include 1 to 50 ohms for the resistance R1 and 1 to 20 volts for a VDRIVE resulting in a current ranging from 0 to 500 milliamps.

[0033] Another illustrative circuit for implementing a current source is illustrated in FIG. 5. This circuit employs a resistor R3 connected between the high voltage capacitor C1 and the high side switches H1, H3. The resistor R3 is switched out of the circuit by a switch SW3 for defibrillator operation and into the circuit for pacing.

[0034] The circuit of FIG. 5 is somewhat more energy wasteful but will work with the use of a high voltage switch for SW3. In the circuit of FIG. 5, the switches H1, H2; L1, L2 are manipulated so as to place the resistor R3 in series with the output. The amount of current may then be selected by the voltage to which the capacitor C1 is charged. As an example, assuming the patient resistance RPAT varies from 30-150 ohms, selecting a resistor R3 of anywhere from 500-5000 ohms, i.e., a resistance that is much larger than that of the patient, results in an approximation of an ideal current source. The approximation is:
i=VHVR3+RPAT(3)

[0035] While creation of a current source according to FIG. 5 is relatively easy, switching the circuit to the defibrillation mode is more complex. As shown in FIG. 6, a high voltage switch SW3 is connected across the series resistor R3 to switch R3 out of the circuit in order to enter the defibrillation mode. Since the high voltage switch SW3 is a floating switch, a high side driver 19 is also needed. These considerations render the circuit of FIG. 6 more difficult to implement in an implantable device.

[0036] In contrast, the circuits of FIGS. 3 and 4 require a switch, e.g., SW1 to switch to the defibrillation mode, but the switch SW1 does not have to be a high voltage switch. Instead, the switch SWi need only be a smaller, low voltage device having the capacity to pass the defibrillation current. In an illustrative circuit, there may be on the order of only 10 volts across SW1, which is advantageous.

[0037] Thus, only a low voltage switch need be used in the circuits of FIGS. 3 and 4. No low voltage driver is necessary since the switch SW1 is referenced to ground and can therefore be driven directly. A high side driver circuit is unnecessary. In either of the circuits of FIG. 3 or FIG. 4, the voltage VDRIVE is preferably implemented by a DAC, either connected to directly drive the resistor R1 (FIG. 3) or to drive the resistor R3 through an op-amp A1 (FIG. 4).

[0038] Provision of a constant current has the advantage of maintaining a constant current density across the heart, irrespective of the electrode interface impedance.

[0039] While the present invention has been described above in terms of specific embodiments, it is to be understood that the invention is not limited to the disclosed embodiments. On the contrary, the following claims are intended to cover various modifications and equivalent methods and structures included within the spirit and scope of the invention.